In Brief: Bracco Lumenhance
Executive Summary
Bracco Lumenhance: FDA deems NDA 20-686 for the oral gastrointestinal magnetic resonance imaging agent manganese chloride "approvable" Dec. 18. Bracco obtained Lumenhance through its 1994 acquisition of Squibb Diagnostics; Squibb acquired the agent from Tucson, Az.-based ImaRx...